A Window of Opportunity: Maximizing the Effectiveness of New HCV Regimens in the United States With the Expansion of the Affordable Care Act.

• Autores: Sean J. Haley, Mary Jeanne Kreek
• Localización: American journal of public health, ISSN 0090-0036, Vol. 105, Nº. 3, 2015, págs. 457-463
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Patients with chronic HCV have predictable overlapping comorbidities that reduce access to care. The Affordable Care Act (ACA) presents an opportunity to focus on the benefits of the medical home model for integrated chronic disease management. New, highly effective HCV treatment regimens in combination with the medical home model could reduce disease prevalence. We sought to address challenges posed by comorbidities in patients with chronic HCV infection and limitations within our health care system, and recommend solutions to maximize the public benefit from ACA and the new drug regimen. [ABSTRACT FROM AUTHOR]